U.S. Food And Drug Administration (FDA)

Showing 25-32 of 48 results

Meet Twirla—a new, lower dose patch

A new lower dose estrogen patch is now available!

Research roundup: May 2021 edition

Pre-treatment with mifepristone for pain management in first-trimester surgical abortion care, high patient and provider satisfaction with telemedicine contraceptive counseling, an update to the CDC’s recommendation on self-administered DMPA-SC, and more.

How to answer your patient’s most frequently asked questions about abortion

Honest answers—supported by facts and research—and patient resources too!

Research roundup: April 2021 edition

Public health benefits of widespread HPV vaccination, potential for IUDs to be placed as emergency contraception 6-14 days after unprotected vaginal sex, etonogestrel implants to help with pelvic pain, and more.

Research roundup: March 2021 edition

Importance of trans-inclusive clinics and accessible education on evidence-based self-managed abortion techniques for gender-expansive individuals, an update to the CDC’s treatment guidelines for gonococcal infection, the effects of stigma and barriers to access on abortion method preference, and more.

Meet Phexxi—a hormone-free, user-controlled prescription birth control gel

Used only when needed, Phexxi changes the vaginal pH in the presence of semen to prevent pregnancy.

Research roundup: February 2021 edition

Comparable effectiveness of Levonorgestrel and copper IUDs as emergency contraception, use of the Natural Cycles app for fertility awareness contraceptive method, transcutaneous electrical nerve stimulation as highly effective pain management in medication abortion care, and more.

DMPA-SQ: A Provider’s Guide

A quick reference guide and resources for providers on prescribing and managing subcutaneous (SQ) administration of the birth control shot at home.
  • Previous
  • 2
  • 3
  • 4(current)
  • 5
  • 6
  • Next